Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENSE: Etravirine vs Efavirenz in Naive HIV-1
NCT00903682Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2009
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Jun 2009; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00903682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903682.